Synapse - Myeloma

Search Within

Myeloma

Results (1016)

Sustained minimal residual disease negativity in newly diagnosed multiple myeloma (NDMM) patients treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) followed by 2 years of lenalidomide maintenance (CRd-R): Updated results of a phase 2 study

Meeting Abstract

Kazandjian, D.; Korde, N. S.; Roschewski, M.; Mailankody, S.; Morrison, C.; Manasanch, E. E.; Kwok, M. L.; Tageja, N.; Bhutani, M.; Zingone, A.; more...
Blood (2016)

Fulltext@MSK | Save

Longitudinal (18)f-FDG-PET-CT analysis in newly diagnosed multiple myeloma (NDMM) patients following carfilzomib, lenalidomide, dexamethasone induction and lenalidomide maintenance (CRd-R)

Meeting Abstract

Korde, N. S.; Kazandjian, D.; Roschewski, M.; Mailankody, S.; Hultcrantz, M.; Yuan, C. M.; Stetler-Stevenson, M.; Choyke, P.; Hassoun, H.; Lesokhin, A. M.; more...
Blood (2016)

Fulltext@MSK | Save

The impact of prior malignancies on second malignancies and survival in MM patients: A population-based study

Meeting Abstract

Jonsdottir, G.; Lund, S. H.; Björkholm, M.; Turesson, I.; Wahlin, A.; Hultcrantz, M.; Porwit, A.; Landgren, O.; Kristinsson, S. Y.
Blood (2016)

Fulltext@MSK | Save

Sustained high rates of complete response and minimal residual disease negativity after 8 cycles of carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX) followed by 2 years of lenalidomide maintenance (CRd-R) in patients with high-risk smoldering multiple myeloma: Updated results of clinical and correlative phase 2 study

Meeting Abstract

Kazandjian, D.; Korde, N. S.; Roschewski, M.; Mailankody, S.; Morrison, C.; Manasanch, E. E.; Kwok, M. L.; Tageja, N.; Bhutani, M.; Zingone, A.; more...
Blood (2016)

Fulltext@MSK | Save

Comparison of standard assays (serum immunofixation and protein electrophoresis) with Hevylite assay in patients with multiple myeloma

Meeting Abstract

Hassoun, H.; Ruiz, R.; Kazunori, M.; Azzi, K.; Devlin, S.; Cooper, B.; Lendvai, N.; Landau, H.; Lesokhin, A. M.; Chung, D. J.; more...
Blood (2016)

Fulltext@MSK | Save

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy

Meeting Abstract

Hassoun, H.; Roshal, M.; Sabari, J.; Cooper, B.; Nguyen, J.; Ruiz, R.; Gao, Q.; Landau, H.; Lendvai, N.; Chung, D. J.; more...
Blood (2016)

Fulltext@MSK | Save

A phase 1b study investigating carfilzomib administered once weekly in combination with lenalidomide and dexamethasone in patients with multiple myeloma

Meeting Abstract

Biran, N.; Siegel, D. S.; Berdeja, J. G.; Faber, E.; Seneviratne, L.; Alsina, M.; Bensinger, W.; Kimball, A. S.; Zhou, K.; Landgren, O.
Blood (2016)

Fulltext@MSK | Save

Transjugular liver biopsy in a multiple myeloma patient with hepatomegaly, portal hypertension and “miliary” liver lesions: A case report

Journal Article

Gonzalez-Aguirre, A. J.; Lin, O.; Cho, C.; Lesokhin, A. M.; Maybody, M.
Journal of Gastrointestinal & Digestive System (2016)

Fulltext@MSK | Save

Bloodstream infections in patients with chronic lymphocytic leukemia: A longitudinal single-center study

Journal Article

Kjellander, C.; Björkholm, M.; Källman, O.; Giske, C. G.; Weibull, C. E.; Löve, T. J.; Landgren, O.; Kristinsson, S. Y.
Annals of Hematology (2016)

Fulltext@MSK | Save

Nivolumab re-treatment in patients with relapsed/refractory Hodgkin lymphoma: Safety and efficacy outcomes from a phase 1 clinical trial

Meeting Abstract

Ansell, S.; Armand, P.; Timmerman, J.; Shipp, M.; Popa McKiver, M.; Zhu, L.; Lesokhin, A. M.
Haematologica (2016)

Fulltext@MSK | Save